115056 - A prospective study to evaluate the safety, effectiveness and impact of the RTS, S/AS01E vaccine in young children in sub-Saharan Africa (EPI-MALARIA-003 VS AME)

20/03/2019
23/04/2025
EU PAS number:
EUPAS28541
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

gsk-115056-protocol-redact-02

English (1.92 MB - PDF) View document
Updated protocol

Protocol Amendment 3 Anonymised 14 Apr 2025.pdf

First published: 22/04/2025
English (2.68 MB - PDF) View document
Study results
Study report
Other information